NO20033715L - Nye sammensetninger - Google Patents

Nye sammensetninger

Info

Publication number: NO20033715L
Authority: NO; Norway
Prior art keywords: new compositions; compositions; new
Prior art date: 1999-09-07

Application number

NO20033715A

Other languages

English (en)

Other versions

NO331825B1 (no

NO20033715D0 (no

Inventor

Martine Anne Cecil Wettendorff

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-07

Filing date

2003-08-21

Publication date

2002-04-30

2002-04-30 Publication of NO20033715L publication Critical patent/NO20033715L/no

2003-08-21 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2003-08-21 Publication of NO20033715D0 publication Critical patent/NO20033715D0/no

2012-04-10 Publication of NO331825B1 publication Critical patent/NO331825B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09C—RECLAMATION OF CONTAMINATED SOIL
- B09C1/00—Reclamation of contaminated soil
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02D—FOUNDATIONS; EXCAVATIONS; EMBANKMENTS; UNDERGROUND OR UNDERWATER STRUCTURES
- E02D3/00—Improving or preserving soil or rock, e.g. preserving permafrost soil
- E02D3/11—Improving or preserving soil or rock, e.g. preserving permafrost soil by thermal, electrical or electro-chemical means
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Soil Sciences (AREA)
Environmental & Geological Engineering (AREA)
Structural Engineering (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Life Sciences & Earth Sciences (AREA)
Mining & Mineral Resources (AREA)
Paleontology (AREA)
Civil Engineering (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Agronomy & Crop Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

NO20033715A 1999-09-07 2003-08-21 HPV viruslignende partikkel samt vaksine NO331825B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9921146A GB9921146D0 (en)	1999-09-07	1999-09-07	Novel composition
PCT/EP2000/008784 WO2001017551A2 (en)	1999-09-07	2000-09-07	Combined vaccine compositions

Publications (3)

Publication Number	Publication Date
NO20033715L true NO20033715L (no)	2002-04-30
NO20033715D0 NO20033715D0 (no)	2003-08-21
NO331825B1 NO331825B1 (no)	2012-04-10

Family

ID=10860520

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20021116A NO332800B1 (no)	1999-09-07	2002-03-06	Vaksinesammensetning egnet for behandling eller profylakse av humanpapillomavirusinfeksjoner og herpes simpleksvirusinfeksjoner
NO20033715A NO331825B1 (no)	1999-09-07	2003-08-21	HPV viruslignende partikkel samt vaksine
NO2012016C NO2012016I1 (no)	1999-09-07	2012-10-08	Kombinasjon av HPV16 og HPV18 L1 viruslignende partikler

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20021116A NO332800B1 (no)	1999-09-07	2002-03-06	Vaksinesammensetning egnet for behandling eller profylakse av humanpapillomavirusinfeksjoner og herpes simpleksvirusinfeksjoner

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2012016C NO2012016I1 (no)	1999-09-07	2012-10-08	Kombinasjon av HPV16 og HPV18 L1 viruslignende partikler

Country Status (33)

Country	Link
US (3)	US6936255B1 (no)
EP (3)	EP1769806A3 (no)
JP (2)	JP4689910B2 (no)
KR (2)	KR100557665B1 (no)
CN (2)	CN1325117C (no)
AR (1)	AR025502A1 (no)
AT (2)	ATE321569T1 (no)
AU (1)	AU766494B2 (no)
BR (1)	BR0014171A (no)
CA (2)	CA2384064C (no)
CO (1)	CO5280045A1 (no)
CY (2)	CY1107457T1 (no)
CZ (2)	CZ302811B6 (no)
DE (2)	DE60027029T2 (no)
DK (2)	DK1210113T3 (no)
ES (2)	ES2261243T3 (no)
GB (1)	GB9921146D0 (no)
GC (1)	GC0000201A (no)
HK (1)	HK1048435B (no)
HU (2)	HU228687B1 (no)
IL (3)	IL158107A0 (no)
MX (1)	MXPA02002484A (no)
MY (2)	MY142842A (no)
NO (3)	NO332800B1 (no)
NZ (2)	NZ517621A (no)
PL (2)	PL201264B1 (no)
PT (1)	PT1210113E (no)
SG (1)	SG110072A1 (no)
SI (2)	SI1410805T1 (no)
TR (1)	TR200200607T2 (no)
TW (1)	TWI258374B (no)
WO (1)	WO2001017551A2 (no)
ZA (2)	ZA200306402B (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US20060029617A1 (en) *	1997-10-03	2006-02-09	Charreyre Catherine E	Porcine circovirus and Helicobacter combination vaccines and methods of use
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2628744T3 (es)	1998-05-22	2017-08-03	Ottawa Hospital Research Institute	Métodos y productos para inducir inmunidad en mucosas
JP2003519084A (ja)	1998-10-16	2003-06-17	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
US20050002958A1 (en) *	1999-06-29	2005-01-06	Smithkline Beecham Biologicals Sa	Vaccines
GB9921147D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
DE60126737T2 (de) *	2001-03-23	2007-11-08	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Modifizierte HPV E6- und E7-Gene und -Proteine als Impfstoff
GB0110431D0 (en) *	2001-04-27	2001-06-20	Glaxosmithkline Biolog Sa	Novel compounds
GB0206360D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
AU2003232951B2 (en) †	2002-05-17	2009-07-23	University Of Cape Town	Chimaeric human papillomavirus 16 L1 proteins comprising an L2 peptide, virus-like particles prepared therefrom and a method for preparing the particles.
JP2005533855A (ja)	2002-07-24	2005-11-10	インターツェル・アクチェンゲゼルシャフト	病原性ウイルスからの別のリーディングフレームによりコードされる抗原
EP1537418A2 (en)	2002-09-13	2005-06-08	Intercell AG	Method for isolating hepatitis c virus peptides
CN101948835A (zh)	2002-10-29	2011-01-19	科勒制药集团股份有限公司	Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
WO2004053104A2 (en)	2002-12-11	2004-06-24	Coley Pharmaceutical Group, Inc.	5’ cpg nucleic acids and methods of use
UA85377C2 (ru) *	2002-12-20	2009-01-26	Глаксосмітклайн Байолоджикалз Са	Применение композиции, содержащей вирусоподобные частички hpv16 і hpv18 при приготовлении медикамента для профилактики инфекции и/или болезни, вызванной группой hpv онкогенных типов, способы индуцирования иммунной реакции, профилактики инфекции и/или болезни, профилактики в популяции субъектов инфекции вызванных одной или несколькими группами онкогенных типов hpv, вакцинная композиция, которая включает hpv16 і нр18
US7858098B2 (en) *	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
OA13147A (en) *	2002-12-20	2006-12-13	Glaxosmithkline Biolog Sa	HPV-16 and -18 L1 VLP vaccine.
AU2004224746B2 (en)	2003-03-24	2009-04-23	Valneva Austria Gmbh	Improved vaccines
WO2004084937A1 (en) *	2003-03-24	2004-10-07	Intercell Ag	Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
GB0413510D0 (en) *	2004-06-16	2004-07-21	Glaxosmithkline Biolog Sa	Vaccine
US7758866B2 (en)	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
PL1758609T3 (pl) *	2004-06-16	2013-02-28	Glaxosmithkline Biologicals Sa	Szczepionka przeciw HPV16 i HPV18 oraz co najmniej jednemu HPV innego typu wybranemu spośród HPV 31, 45 lub 52
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
SG160328A1 (en) *	2005-02-16	2010-04-29	Novartis Vaccines & Diagnostic	Adjuvant composition comprising aluminium phosphate and 3d-mpl
JP4182074B2 (ja)	2005-03-03	2008-11-19	ファナック株式会社	ハンド及びハンドリングロボット
EA200701787A1 (ru) *	2005-03-23	2008-08-29	Глаксосмитклайн Байолоджикалс С.А.	Иммунная композиция, способ ее изготовления, ее применение и способ вакцинации
EA013326B1 (ru) *	2005-04-26	2010-04-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
AR053715A1 (es) *	2005-04-26	2007-05-16	Glaxosmithkline Biolog Sa	Vacuna multivalente de vph
US7790203B2 (en) *	2005-12-13	2010-09-07	Lowder Tom R	Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
DK3127551T3 (da)	2005-12-29	2020-10-12	Boehringer Ingelheim Animal Health Usa Inc	Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
US20080226669A1 (en)	2005-12-29	2008-09-18	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions and methods of producing such compositions
WO2008027394A2 (en)	2006-08-28	2008-03-06	The Wistar Institute Of Anatomy And Biology	Constructs for enhancing immune responses
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
PT2484375T (pt)	2006-09-26	2018-07-09	Infectious Disease Res Inst	Composição para vacina contendo adjuvante sintético
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
JP2010520874A (ja)	2007-03-09	2010-06-17	メルク・シャープ・エンド・ドーム・コーポレイション	パピローマウイルスワクチン組成物
JP5540329B2 (ja)	2007-06-26	2014-07-02	公益財団法人ヒューマンサイエンス振興財団	高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009147980A1 (ja)	2008-06-04	2009-12-10	財団法人化学及血清療法研究所	不活化日本脳炎ウイルス粒子をアジュバントとして使用する方法
BRPI0916732B1 (pt) *	2008-07-31	2021-06-29	Glaxosmithkline Biologicals S.A.	Vacina para a prevenção de doença ou infecção relacionada ao papilomavirus humano (hpv) compreendendo partículas semelhantes ao vírus hpv 16 e hpv 18
AU2010249330B2 (en)	2009-05-22	2015-11-05	Genocea Biosciences Inc.	Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
US8722064B2 (en)	2009-06-05	2014-05-13	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
MX2011013566A (es) *	2009-06-19	2012-06-28	Eyegene Inc	Vacunas para cancer cervical.
AU2010264695A1 (en) *	2009-06-25	2012-01-19	Glaxosmithkline Biologicals S.A.	Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
HRP20181039T1 (hr) *	2010-05-28	2018-08-24	Zoetis Belgium S.A.	Cjepiva koja sadrže kolesterol i cpg kao jedine molekule koje nose adjuvans
UA112970C2 (uk) *	2010-08-05	2016-11-25	Мерк Шарп Енд Доме Корп.	Інактивований вірус вітряної віспи, спосіб його одержання і застосування
EP2609428B1 (en) *	2010-08-27	2016-02-10	Intervet International B.V.	Potency test for vaccine formulations
CN102008721A (zh) *	2010-11-16	2011-04-13	浙江大学	一种hpv多肽/dc混合疫苗及其制备
AU2011336894B2 (en)	2010-11-24	2016-11-17	Genocea Biosciences, Inc.	Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
AU2012243039B2 (en)	2011-04-08	2017-07-13	Immune Design Corp.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CN102210858B (zh) *	2011-05-18	2013-05-08	北京科兴生物制品有限公司	一种肠道病毒71型与甲型肝炎联合疫苗
RU2610174C2 (ru)	2011-06-24	2017-02-08	Мерк Шарп И Доум Корп.	Вакцинные составы против вируса папилломы человека (hpv), содержащие алюминиевый адъювант, и способы их получения
EP2726097A4 (en) *	2011-07-01	2015-03-11	Univ California	HERPES VIRUS VACCINE AND METHOD OF USE
AU2012340712B2 (en)	2011-11-23	2017-09-14	Genocea Biosciences, Inc.	Nucleic acid vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
LT2811981T (lt)	2012-02-07	2019-06-10	Infectious Disease Research Institute	Pagerintos adjuvanto kompozicijos, apimančios tlr4 agonistus, ir jų panaudojimo būdai
SG11201407586WA (en)	2012-05-16	2014-12-30	Immune Design Corp	Vaccines for hsv-2
US9624510B2 (en)	2013-03-01	2017-04-18	The Wistar Institute	Adenoviral vectors comprising partial deletions of E3
HK1214510A1 (zh)	2013-04-18	2016-07-29	Immune Design Corp.	用於癌症治疗的gla单一疗法
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
IL310015B1 (en)	2013-12-31	2025-10-01	Access To Advanced Health Inst	Single vial formulation
WO2018026547A1 (en)	2016-08-01	2018-02-08	The Wistar Institute Of Anatomy And Biology	Compositions and methods of replication deficient adenoviral vectors for vaccine applications
EP3519427A4 (en)	2016-09-28	2020-03-11	Genocea Biosciences Inc.	METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES
CN107987159B (zh) *	2017-11-28	2021-06-22	上海药明生物医药有限公司	一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法
GB201821207D0 (en)	2018-12-24	2019-02-06	Tcer Ab	Immunotherapy therapy
KR20220125149A (ko)	2019-05-25	2022-09-14	액세스 투 어드밴스드 헬스 인스티튜트	애주번트 백신 에멀션을 분무 건조시키기 위한 조성물 및 방법
CN110576034B (zh) *	2019-10-09	2020-06-30	北京尚华生态环保科技股份公司	一种土壤原位修复方法
CN110652980B (zh) *	2019-10-09	2020-06-30	北京尚华生态环保科技股份公司	一种土壤原位修复剂
EP4058581A1 (en)	2019-11-15	2022-09-21	Infectious Disease Research Institute	Rig-i agonist and adjuvant formulation for tumor treatment
CN114681602B (zh) *	2020-12-25	2023-12-01	中国食品药品检定研究院	一种双价人乳头瘤病毒疫苗
CN114796479A (zh) *	2022-06-02	2022-07-29	金宇保灵生物药品有限公司	一种畜类动物疫苗用水包油包水佐剂及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH085804B2 (ja) *	1988-04-28	1996-01-24	財団法人化学及血清療法研究所	Ａ型及びｂ型肝炎混合アジュバントワクチン
GB9113809D0 (en) *	1991-06-26	1991-08-14	Cancer Res Campaign Tech	Papillomavirus l2 protein
EP1471147A3 (en) *	1991-07-19	2007-03-21	The University Of Queensland	Method of making a recombinant molecule for the expression of HPV-16 L1 protein
US5437951A (en) *	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
US5618536A (en) *	1992-09-03	1997-04-08	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric papillomavirus-like particles
CN1087176C (zh) *	1993-03-23	2002-07-10	史密斯克莱·比奇曼生物公司	含有3－o脱酰基单磷酰脂a的疫苗制剂
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
GB9409962D0 (en) *	1994-05-18	1994-07-06	Smithkline Beecham Biolog	Novel compounds
CA2211995A1 (en) *	1995-02-24	1996-08-29	Cantab Pharmaceuticals Research Limited	Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
US6172192B1 (en) *	1996-01-26	2001-01-09	Innogenetics N.V.	Toxoplasma gondii antigen Tg20
BR9707400A (pt) *	1996-02-09	2000-01-04	Smithkline Beecham Biolog	Vacinas contra produto do gene 63 de vìrus varicella zoster.
GB9711990D0 (en) *	1997-06-11	1997-08-06	Smithkline Beecham Biolog	Vaccine
GB9717953D0 (en) *	1997-08-22	1997-10-29	Smithkline Beecham Biolog	Vaccine
CA2229955C (en) *	1998-02-20	2003-12-09	Medigene Gmbh	Papilloma virus capsomere vaccine formulations and methods of use
CN1299288A (zh) *	1998-03-09	2001-06-13	史密丝克莱恩比彻姆生物有限公司	联合疫苗组合物
US6500284B1 (en)	1998-06-10	2002-12-31	Suraltech, Inc.	Processes for continuously producing fine grained metal compositions and for semi-solid forming of shaped articles
GB9819898D0 (en)	1998-09-11	1998-11-04	Smithkline Beecham Plc	New vaccine and method of use
JP2003519084A (ja)	1998-10-16	2003-06-17	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
PT1150712E (pt) *	1999-02-05	2008-12-22	Merck & Co Inc	Formulações para a vacina do vírus do papiloma humano
GB9921147D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition

1999
- 1999-09-07 GB GB9921146A patent/GB9921146D0/en not_active Ceased
2000
- 2000-09-05 MY MYPI20033661A patent/MY142842A/en unknown
- 2000-09-05 CO CO00066605A patent/CO5280045A1/es not_active Application Discontinuation
- 2000-09-05 AR ARP000104636 patent/AR025502A1/es active IP Right Grant
- 2000-09-05 MY MYPI20004083A patent/MY130084A/en unknown
- 2000-09-06 GC GCP2000892 patent/GC0000201A/en active
- 2000-09-07 WO PCT/EP2000/008784 patent/WO2001017551A2/en not_active Ceased
- 2000-09-07 AT AT00967654T patent/ATE321569T1/de active
- 2000-09-07 IL IL15810700A patent/IL158107A0/xx unknown
- 2000-09-07 AT AT03078635T patent/ATE312624T1/de active
- 2000-09-07 HU HU0202804A patent/HU228687B1/hu not_active IP Right Cessation
- 2000-09-07 DK DK00967654T patent/DK1210113T3/da active
- 2000-09-07 HU HU0303215A patent/HU229099B1/hu unknown
- 2000-09-07 TR TR200200607T patent/TR200200607T2/xx unknown
- 2000-09-07 SG SG200305672A patent/SG110072A1/en unknown
- 2000-09-07 MX MXPA02002484A patent/MXPA02002484A/es active IP Right Grant
- 2000-09-07 NZ NZ517621A patent/NZ517621A/en unknown
- 2000-09-07 ES ES00967654T patent/ES2261243T3/es not_active Expired - Lifetime
- 2000-09-07 ES ES03078635T patent/ES2253636T3/es not_active Expired - Lifetime
- 2000-09-07 DK DK03078635T patent/DK1410805T3/da active
- 2000-09-07 PT PT00967654T patent/PT1210113E/pt unknown
- 2000-09-07 EP EP20060075129 patent/EP1769806A3/en not_active Withdrawn
- 2000-09-07 ZA ZA200306402A patent/ZA200306402B/xx unknown
- 2000-09-07 SI SI200030796T patent/SI1410805T1/sl unknown
- 2000-09-07 KR KR1020027003023A patent/KR100557665B1/ko not_active Expired - Fee Related
- 2000-09-07 CA CA 2384064 patent/CA2384064C/en not_active Expired - Fee Related
- 2000-09-07 CN CNB2004100489635A patent/CN1325117C/zh not_active Expired - Lifetime
- 2000-09-07 PL PL362069A patent/PL201264B1/pl unknown
- 2000-09-07 CZ CZ20032326A patent/CZ302811B6/cs not_active IP Right Cessation
- 2000-09-07 SI SI200030859T patent/SI1210113T1/sl unknown
- 2000-09-07 DE DE2000627029 patent/DE60027029T2/de not_active Expired - Lifetime
- 2000-09-07 EP EP20030078635 patent/EP1410805B1/en not_active Expired - Lifetime
- 2000-09-07 HK HK02108383.6A patent/HK1048435B/en not_active IP Right Cessation
- 2000-09-07 JP JP2001521339A patent/JP4689910B2/ja not_active Expired - Fee Related
- 2000-09-07 NZ NZ52756000A patent/NZ527560A/xx not_active IP Right Cessation
- 2000-09-07 CZ CZ2002843A patent/CZ2002843A3/cs unknown
- 2000-09-07 IL IL14845600A patent/IL148456A0/xx not_active IP Right Cessation
- 2000-09-07 AU AU77751/00A patent/AU766494B2/en not_active Ceased
- 2000-09-07 PL PL354039A patent/PL201767B1/pl not_active IP Right Cessation
- 2000-09-07 CA CA 2443214 patent/CA2443214C/en not_active Expired - Lifetime
- 2000-09-07 CN CNB008154244A patent/CN100389824C/zh not_active Expired - Fee Related
- 2000-09-07 BR BR0014171A patent/BR0014171A/pt not_active IP Right Cessation
- 2000-09-07 KR KR1020037013500A patent/KR100594668B1/ko not_active Expired - Lifetime
- 2000-09-07 EP EP20000967654 patent/EP1210113B1/en not_active Expired - Lifetime
- 2000-09-07 US US10/070,479 patent/US6936255B1/en not_active Expired - Fee Related
- 2000-09-07 DE DE2000624893 patent/DE60024893T2/de not_active Expired - Lifetime
- 2000-09-19 TW TW92125370A patent/TWI258374B/zh not_active IP Right Cessation
2002
- 2002-03-05 ZA ZA200201810A patent/ZA200201810B/xx unknown
- 2002-03-06 NO NO20021116A patent/NO332800B1/no not_active IP Right Cessation
2003
- 2003-08-20 JP JP2003296403A patent/JP2004067696A/ja active Pending
- 2003-08-21 NO NO20033715A patent/NO331825B1/no not_active IP Right Cessation
- 2003-09-25 IL IL158107A patent/IL158107A/en active IP Right Grant
- 2003-12-12 US US10/734,857 patent/US7101560B2/en not_active Expired - Lifetime
2006
- 2006-02-01 CY CY061100126T patent/CY1107457T1/el unknown
- 2006-06-05 CY CY20061100713T patent/CY1106090T1/el unknown
- 2006-06-29 US US11/477,879 patent/US7220551B2/en not_active Expired - Lifetime
2012
- 2012-10-08 NO NO2012016C patent/NO2012016I1/no unknown

Also Published As

Publication number	Publication date
CA2384064A1 (en)	2001-03-15
DK1210113T3 (da)	2006-07-03
CY1106090T1 (el)	2011-06-08
AU766494B2 (en)	2003-10-16
GC0000201A (en)	2006-03-29
CY1107457T1 (el)	2012-12-19
NO20021116L (no)	2002-04-30
CA2443214C (en)	2006-03-21
SI1410805T1 (sl)	2006-04-30
ES2253636T3 (es)	2006-06-01
DE60027029T2 (de)	2006-10-19
HK1064958A1 (en)	2005-02-08
SI1210113T1 (sl)	2006-08-31
GB9921146D0 (en)	1999-11-10
HUP0303215A3 (en)	2008-04-28
ZA200306402B (en)	2004-08-02
EP1210113A2 (en)	2002-06-05
CO5280045A1 (es)	2003-05-30
CN1618465A (zh)	2005-05-25
NO331825B1 (no)	2012-04-10
ES2261243T3 (es)	2006-11-16
IL158107A (en)	2008-11-03
DE60027029D1 (de)	2006-05-18
EP1210113B1 (en)	2006-03-29
DE60024893D1 (de)	2006-01-19
KR20030087081A (ko)	2003-11-12
CA2384064C (en)	2010-06-01
ATE321569T1 (de)	2006-04-15
TWI258374B (en)	2006-07-21
AR025502A1 (es)	2002-11-27
EP1769806A3 (en)	2007-10-24
MY142842A (en)	2011-01-14
SG110072A1 (en)	2005-04-28
HK1048435A1 (en)	2003-04-04
EP1410805A1 (en)	2004-04-21
CZ302811B6 (cs)	2011-11-23
NZ517621A (en)	2003-09-26
BR0014171A (pt)	2002-05-21
MXPA02002484A (es)	2002-08-28
US7101560B2 (en)	2006-09-05
PL201767B1 (pl)	2009-05-29
TR200200607T2 (tr)	2002-06-21
HU228687B1 (en)	2013-05-28
JP2003508495A (ja)	2003-03-04
JP4689910B2 (ja)	2011-06-01
HU229099B1 (en)	2013-07-29
NO2012016I2 (no)	2012-10-08
MY130084A (en)	2007-05-31
HUP0202804A2 (hu)	2002-12-28
PL354039A1 (en)	2003-12-15
US7220551B2 (en)	2007-05-22
DE60024893T2 (de)	2006-07-06
HU0303215D0 (en)	2003-11-28
CA2443214A1 (en)	2001-03-15
NO20021116D0 (no)	2002-03-06
KR100557665B1 (ko)	2006-03-06
CZ2002843A3 (cs)	2002-08-14
PT1210113E (pt)	2006-07-31
IL158107A0 (en)	2004-03-28
NO2012016I1 (no)	2012-10-15
WO2001017551A2 (en)	2001-03-15
KR100594668B1 (ko)	2006-06-30
CN100389824C (zh)	2008-05-28
CN1387443A (zh)	2002-12-25
ZA200201810B (en)	2004-05-26
PL201264B1 (pl)	2009-03-31
EP1410805B1 (en)	2005-12-14
EP1769806A2 (en)	2007-04-04
NO332800B1 (no)	2013-01-14
IL148456A0 (en)	2002-09-12
HUP0202804A3 (en)	2004-08-30
KR20020027630A (ko)	2002-04-13
ATE312624T1 (de)	2005-12-15
US20060280756A1 (en)	2006-12-14
TW200408405A (en)	2004-06-01
US6936255B1 (en)	2005-08-30
NO20033715D0 (no)	2003-08-21
WO2001017551A3 (en)	2001-09-27
AU7775100A (en)	2001-04-10
DK1410805T3 (da)	2006-04-18
CN1325117C (zh)	2007-07-11
US20040126394A1 (en)	2004-07-01
NZ527560A (en)	2004-12-24
HK1048435B (en)	2007-01-05
JP2004067696A (ja)	2004-03-04

Publication	Publication Date	Title
NO20033715D0 (no)	2003-08-21	Nye sammensetninger
NO20015074L (no)	2001-11-15	Nye sammensetninger
NO20014518L (no)	2001-09-17	Nye forbindelser
DK1202994T3 (da)	2004-08-02	Nye forbindelser
AR023440A1 (es)	2002-09-04	Composiciones antitranspirantes
IS6120A (is)	2001-10-22	Lyfjablanda
NO20021436L (no)	2002-06-19	Nye forbindelser
NO20005832L (no)	2001-01-18	Nye spesielle formuleringer
DE60021018D1 (de)	2005-08-04	Polymerzusammensetzungen
NO20020810D0 (no)	2002-02-19	Nye fenylpiperaziner
ID29785A (id)	2001-10-11	Komposisi-komposisi sampo
ATE257691T1 (de)	2004-01-15	Schweisshemmende zusammensetzungen
NO20015383D0 (no)	2001-11-02	Nye forbindelser
DK1237857T3 (da)	2004-09-20	Nye Phenalkyloxyphenylderivater
DE60015460D1 (de)	2004-12-09	Polymerzusammensetzungen
NO20034695D0 (no)	2003-10-20	Nye sammensetninger
DE69943245D1 (de)	2011-04-14	Gaserzeugende zusammensetzung
FI19992609L (fi)	2000-12-22	Uusi koostumus
NO20015374L (no)	2001-11-02	Nye forbindelser
DE60020682D1 (de)	2005-07-14	Resorcinenthaltende zusammensetzung
ID27329A (id)	2001-03-29	Komposisi penghambat
NO20014629D0 (no)	2001-09-24	Nye forbindelser
NO20016273L (no)	2001-12-20	Nye forbindelser
NO20022845L (no)	2002-08-08	Limsammensetning
ID30320A (id)	2001-11-22	Komposisi-komposisi berpigmen

Legal Events

Date	Code	Title	Description
2012-10-15	SPCF	Filing of supplementary protection certificate	Free format text: PRODUCT NAME: CERVARIX; NAT. REG. NO/DATE: EU/1/07/419/001-009 20070925; FIRST REG. NO/DATE: EU , EU/1/07/419/001-009 20070924 Spc suppl protection certif: 2012016 Filing date: 20121008
2017-01-30	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: KOMBINASJON AV HPV16 OG HPV18 L1 VIRUSLIGNENDE PARTIKLER; NAT. REG. NO/DATE: EU/1/07/419/001-009 20070925; FIRST REG. NO/DATE: EU , EU/1/07/419/001-009 20070924 Spc suppl protection certif: 2012016 Filing date: 20121008 Extension date: 20220924
2020-10-12	MK1K	Patent expired
2022-10-10	SPCX	Expiry of an spc	Spc suppl protection certif: 2012016 Expiry date: 20220924